1.    Introduction

1.1    Scope of the Study

1.2    The Insight Partners Research Report Guidance

1.3    Market Segmentation

1.3.1    Europe Neurological Biomarkers Market – By Product

1.3.2    Europe Neurological Biomarkers Market – By Application

1.3.3    Europe Neurological Biomarkers Market – By End User

1.3.4    Europe Neurological Biomarkers Market – By Country

2.    Europe Neurological Biomarkers Market – Key Takeaways

3.    Research Methodology

3.1    Coverage

3.2    Secondary Research

3.3    Primary Research

4.    Europe Neurological Biomarkers Market – Market Landscape

4.1    Overview

4.2    PEST Analysis

4.2.1    Neurological Biomarkers Market - Europe PEST Analysis

4.3    Expert Opinion

5.    Europe Neurological Biomarkers Market - Key Market Dynamics

5.1    Key Market Drivers

5.1.1    Rising Prevalence of Neurological Disorders

5.1.2    Progressive Research in Neurological Biomarkers

5.2    Key Market Restraints

5.2.1    Complications Associated with the Use of Neurological Biomarkers

5.3    Market Opportunities

5.3.1    Rising Awareness Regarding Benefits of Early Diagnosis

5.4    Future Trends

5.4.1    Patient Inclination Toward Personalized/Precision Medicine

5.5    Impact analysis

6.    Neurological Biomarkers Market – Europe Analysis

6.1    Europe Neurological Biomarkers Market Revenue Forecasts and Analysis

7.    Europe Neurological Biomarkers Market Analysis And Forecasts To 2027 – By Product

7.1    Overview

7.2    Europe Neurological Biomarkers market, By Product 2019 & 2027 (%)

7.2.1    Europe Neurological Biomarkers Market Revenue and Forecasts to 2027, By Product (US$ Mn)

7.3    Proteomics Biomarker

7.3.1    Overview

7.3.2    Europe Proteomics Biomarker Market Revenue and Forecast to 2027 (US$ Mn)

7.4    Genomics Biomarker

7.4.1    Overview

7.4.2    Europe Genomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)

7.5    Metabolomics Biomarker

7.5.1    Overview

7.5.2    Europe Metabolomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)

7.6    Imaging Biomarker

7.6.1    Overview

7.6.2    Europe Imaging Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)

7.7    Others

7.7.1    Overview

7.7.2    Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)

8.    Europe Neurological Biomarkers Market Analysis – By Application

8.1    Overview

8.2    Europe Neurological Biomarkers Market, By Application 2019-2027 (%)

8.2.1    Europe Neurological Biomarkers Market Revenue and Forecasts to 2027, By Application (US$ Mn)

8.3    Alzheimer’s Disease

8.3.1    Overview

8.3.2    Europe Alzheimer’s Disease Market Revenue and Forecasts to 2027 (US$ Mn)

8.4    Parkinson’s Disease

8.4.1    Overview

8.4.2    Europe Parkinson’s Disease Market Revenue and Forecasts to 2027 (US$ Mn)

8.5    Schizophrenia

8.5.1    Overview

8.5.2    Europe Schizophrenia Market Revenue and Forecasts to 2027 (US$ Mn)

8.6    Huntington's Disease

8.6.1    Overview

8.6.2    Europe Huntington's Disease Market Revenue and Forecasts to 2027 (US$ Mn)

8.7    Spinal Muscular Atrophy

8.7.1    Overview

8.7.2    Europe Spinal Muscular Atrophy Market Revenue and Forecasts to 2027 (US$ Mn)

8.8    Others

8.8.1    Overview

8.8.2    Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)

9.    Europe Neurological Biomarkers Market Analysis – By End User

9.1    Overview

9.2    Europe Neurological Biomarkers Market, By End User 2019-2027 (%)

9.2.1    Europe Neurological Biomarkers Market Revenue and Forecasts to 2027, By End User (US$ Mn)

9.3    Pharmaceutical and Biotechnology Companies

9.3.1    Overview

9.3.2    Europe Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2027 (US$ Mn)

9.4    Clinical Diagnostics

9.4.1    Overview

9.4.2    Europe Clinical Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

9.5    Research Organizations

9.5.1    Overview

9.5.2    Europe Research Organizations Market Revenue and Forecasts to 2027 (US$ Mn)

10.    Neurological Biomarkers Market Revenue and Forecasts To 2027 – Geographical Analysis

10.1    Europe: Neurological Biomarker Market

10.1.1    Overview

10.1.2    Europe: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)

10.1.3    Europe: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)

10.1.4    Europe: Neurological Biomarker Market, by Application, 2018–2027 (USD Million)

10.1.5    Europe: Neurological Biomarker Market, by End-User, 2018–2027 (USD Million)

10.1.6    Europe: Neurological Biomarker Market, by Country, 2019& 2027 (%)

10.1.7    Germany: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.1    Germany: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.2    Germany: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)

10.1.7.3    Germany: Neurological Biomarker Market, by Application, 2018–2027 (USD Million)

10.1.7.4    Germany: Neurological Biomarker Market, by End-User, 2018–2027 (USD Million)

10.1.8    United Kingdom: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.1    United Kingdom: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.2    United Kingdom: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)

10.1.8.3    United Kingdom: Neurological Biomarker Market, by Application, 2018–2027 (USD Million)

10.1.8.4    United Kingdom: Neurological Biomarker Market, by End-User, 2018–2027 (USD Million)

10.1.9    France: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.1    France: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.2    France: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)

10.1.9.3    France: Neurological Biomarker Market, by Application, 2018–2027 (USD Million)

10.1.9.4    France: Neurological Biomarker Market, by End-User, 2018–2027 (USD Million)

10.1.10  Spain: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.1.10.1   Spain: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.1.10.2   Spain: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)

10.1.10.3   Spain: Neurological Biomarker Market, by Application, 2018–2027 (USD Million)

10.1.10.4   Spain: Neurological Biomarker Market, by End-User, 2018–2027 (USD Million)

10.1.11  Italy: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.1.11.1   Italy: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.1.11.2   Italy: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)

10.1.11.3   Italy: Neurological Biomarker Market, by Application, 2018–2027 (USD Million)

10.1.11.4   Italy: Neurological Biomarker Market, by End-User, 2018–2027 (USD Million)

11.   Impact of COVID-19 Pandemic on Europe Neurological Biomarkers Market

11.1    Europe: Impact Assessment Of COVID-19 Pandemic

12.   Company Profiles

12.1    Myriad Genetics, Inc.

12.1.1    Key Facts

12.1.2    Business Description

12.1.3    Products and Services

12.1.4    Financial Overview

12.1.5    SWOT Analysis

12.1.6    Key Developments

12.2    QIAGEN

12.2.1    Key Facts

12.2.2    Business Description

12.2.3    Products and Services

12.2.4    Financial Overview

12.2.5    SWOT Analysis

12.2.6    Key Developments

12.3    MERCK KGaA

12.3.1    Key Facts

12.3.2    Business Description

12.3.3    Products and Services

12.3.4    Financial Overview

12.3.5    SWOT Analysis

12.3.6    Key Developments

12.4    Thermo Fisher Scientific Inc.

12.4.1    Key Facts

12.4.2    Business Description

12.4.3    Products and Services

12.4.4    Financial Overview

12.4.5    SWOT Analysis

12.4.6    Key Developments

12.5    Abbott

12.5.1    Key Facts

12.5.2    Business Description

12.5.3    Products and Services

12.5.4    Financial Overview

12.5.5    SWOT Analysis

12.5.6    Key Developments

13.   Appendix

13.1    About the Insight Partners

13.2    Word Index

LIST OF TABLES

Table 1.    Europe Neurological Biomarkers Market Revenue and Forecasts To 2027, By Product (US$ Mn)

Table 2.    Europe Neurological Biomarkers Market Revenue and Forecasts To 2027, By Application (US$ Mn)

Table 3.    Europe Neurological Biomarkers Market Revenue and Forecasts To 2027, By End User (US$ Mn)

Table 4.    Europe Neurological Biomarker Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 5.    Europe Neurological Biomarker Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 6.    Europe Neurological Biomarker Market, by End-User– Revenue and Forecast to 2027 (USD Million)

Table 7.    US Neurological Biomarker Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 8.    US Neurological Biomarker Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 9.    US Neurological Biomarker Market, by End-User– Revenue and Forecast to 2027 (USD Million)

Table 10.    Canada Neurological Biomarker Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 11.    Canada Neurological Biomarker Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 12.    Canada Neurological Biomarker Market, by End-User– Revenue and Forecast to 2027 (USD Million)

Table 13.    Mexico Neurological Biomarker Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 14.    Mexico Neurological Biomarker Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 15.    Mexico Neurological Biomarker Market, by End-User– Revenue and Forecast to 2027 (USD Million)

Table 16.    List of Abbreviation

LIST OF FIGURES

Figure 1.    Neurological Biomarkers Market Segmentation

Figure 2.    Europe Neurological Biomarkers Market Overview

Figure 3.    Genomic Biomarkers Segment Held Largest Share of Neurological Biomarker Market

Figure 4.    US is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.    Europe Neurological Biomarkers Market - Leading Country Markets (US$ Mn)

Figure 6.    Neurological Biomarkers Market - Europe PEST Analysis

Figure 7.    Neurological Biomarkers Market Impact Analysis Of Driver And Restraints

Figure 8.    Europe Neurological Biomarkers market – Revenue Forecasts and Analysis – 2019- 2027

Figure 9.    Europe Neurological Biomarkers market, By Product 2019 & 2027 (%)

Figure 10.    Europe Proteomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 11.    Europe Genomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 12.    Europe Metabolomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 13.    Europe Imaging Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 14.    Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 15.    Europe Neurological Biomarkers Market, by Application 2019 & 2027 (%)

Figure 16.    Europe Alzheimer’s Disease Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 17.    Europe Parkinson’s Disease Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 18.    Europe Schizophrenia Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 19.    Europe Huntington's Disease Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 20.    Europe Spinal Muscular Atrophy Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 21.    Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 22.    Europe Neurological Biomarkers Market, by End User 2019 & 2027 (%)

Figure 23.    Europe Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 24.    Europe Clinical Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 25.    Europe Research Organizations Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 26.    Europe: Neurological Biomarker Market, by Key Country – Revenue (2019) (USD Million)

Figure 27.    Europe Neurological Biomarker Market Revenue and Forecast to 2027 (USD Million)

Figure 28.    Europe: Neurological Biomarker Market, by Country, 2019 & 2027 (%)

Figure 29.    US: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

Figure 30.    Canada: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

Figure 31.    Mexico: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

Figure 32.    Impact of COVID-19 Pandemic in Europen Country Markets